Assignee
SHANGHAI SIMR BIOTECHNOLOGY CO LTD
CN·1 granted patent·6 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
7 records- 0155US2025215016A1Isoxazole-heterocyclic derivative, pharmaceutical composition and useSHANGHAI SIMR BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0255US2025163078A1Imidazopyridazine derivative, and preparation method therefor, pharmaceutical composition thereof and use thereofSHANGHAI SIMR BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0353US2025136581A1Substituted triazole derivative, preparation method therefor, pharmaceutical composition thereof, and use thereofSHANGHAI SIMR BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0452US2024246995A1Pyrimidinone derivative and preparation method therefor, pharmaceutical composition, and useSHANGHAI SIMR BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0546US2023136194A1Triazolopyridazine derivative, preparation method therefor, pharmaceutical composition thereof, and use thereofSHANGHAI SIMR BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 0643US2023044787A1Tricycle dihydroimidazopyrimidone derivative, preparation method thereof, pharmaceutical composition and use thereofSHANGHAI SIMR BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 0737US11512089B2Substituted [1,2,4]triazolo[3,4-a]phthalazines as modulators of GABAA receptor activitySHANGHAI SIMR BIOTECHNOLOGY CO LTD·Filed 2019·Granted Nov 29, 2022·0 cites·36 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI SIMR BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →